Identification of a common T/natural killer cell progenitor in human fetal thymus - PubMed (original) (raw)

Identification of a common T/natural killer cell progenitor in human fetal thymus

M J Sánchez et al. J Exp Med. 1994.

Abstract

The phenotypic similarities between natural killer (NK) and T cells have led to the hypothesis that these distinctive lymphocyte subsets may be developmentally related and thus may share a common progenitor (Lanier, L. L., H. Spits, and J. H. Phillips, 1992. Immunol. Today. 13:392; Rodewald, H.-R., P. Moingeon, J. L. Lurich, C. Dosiou, P. Lopez, and E. L. Reinherz. 1992. Cell. 69:139). In this report, we have investigated the potential of human CD34+ triple negative thymocytes ([TN] CD3-, CD4-, CD8-) to generate both T cells and NK cells in murine fetal thymic organ cultures (mFTOC) and in vitro clonogenic assays. CD34+ TN thymocytes, the majority of which express prominent cytoplasmic CD3 epsilon (cytoCD3 epsilon) protein, can be divided into high (CD34Bright) and low (CD34Dim) surface expressing populations. CD34Bright TN thymocytes were capable of differentiating into T and NK cells when transferred into mFTOC, and demonstrated high NK cell clonogenic capabilities when cultured in interleukin (IL)-2, IL-7, and stem cell factor (SCF). Likewise, CD34Bright TN thymocyte clones after 5 d in culture were capable of generating NK and T cells when transferred into mFTOC but demonstrated clonogenic NK cell differentiation capabilities when maintained in culture with IL-2. CD34Dim TN thymocytes, however, possessed only T cell differentiation capabilities in mFTOC but were not expandable in clonogenic conditions containing IL-2, IL-7, and SCF. No significant differentiation of other cell lineage was detected in either mFTOC or in clonogenic assays from CD34+ TN thymocytes. These results represent the first definitive evidence of a common T/NK cell progenitor in the human fetal thymus and delineate the point in thymocyte differentiation where T and NK cells diverge.

PubMed Disclaimer

Similar articles

• Human natural killer cell committed thymocytes and their relation to the T cell lineage.
  Sánchez MJ, Spits H, Lanier LL, Phillips JH. Sánchez MJ, et al. J Exp Med. 1993 Dec 1;178(6):1857-66. doi: 10.1084/jem.178.6.1857. J Exp Med. 1993. PMID: 7504051 Free PMC article.
• Precursors of CD3+CD4+CD8+ cells in the human thymus are defined by expression of CD34. Delineation of early events in human thymic development.
  Galy A, Verma S, Bárcena A, Spits H. Galy A, et al. J Exp Med. 1993 Aug 1;178(2):391-401. doi: 10.1084/jem.178.2.391. J Exp Med. 1993. PMID: 7688021 Free PMC article.
• Lymphoid and myeloid differentiation of fetal liver CD34+lineage- cells in human thymic organ culture.
  Bárcena A, Galy AH, Punnonen J, Muench MO, Schols D, Roncarolo MG, de Vries JE, Spits H. Bárcena A, et al. J Exp Med. 1994 Jul 1;180(1):123-32. doi: 10.1084/jem.180.1.123. J Exp Med. 1994. PMID: 7516402 Free PMC article.
• CD34-positive early stages of human T-cell differentiation.
  Schmitt C, Ktorza S, Sarun S, Verpilleux MP, Blanc C, Deugnier MA, Dalloul A, Debré P. Schmitt C, et al. Leuk Lymphoma. 1995 Mar;17(1-2):43-50. doi: 10.3109/10428199509051702. Leuk Lymphoma. 1995. PMID: 7539659 Review.
• Fidelity and infidelity in commitment to B-lymphocyte lineage development.
  Rolink AG, Schaniel C, Busslinger M, Nutt SL, Melchers F. Rolink AG, et al. Immunol Rev. 2000 Jun;175:104-11. Immunol Rev. 2000. PMID: 10933595 Review.

Cited by

• Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia.
  Gimenes-Teixeira HL, Lucena-Araujo AR, Dos Santos GA, Zanette DL, Scheucher PS, Oliveira LC, Dalmazzo LF, Silva-Júnior WA, Falcão RP, Rego EM. Gimenes-Teixeira HL, et al. Exp Hematol Oncol. 2013 Apr 8;2(1):10. doi: 10.1186/2162-3619-2-10. Exp Hematol Oncol. 2013. PMID: 23566596 Free PMC article.
• Treatment of a child with myeloid/NK cell precursor acute leukemia with L-asparaginase and unrelated cord blood transplantation.
  Tezuka K, Nakayama H, Honda K, Suzumiya J, Oshima K, Kitoh T, Ishii E. Tezuka K, et al. Int J Hematol. 2002 Feb;75(2):201-6. doi: 10.1007/BF02982029. Int J Hematol. 2002. PMID: 11939270
• Leukemia and lymphoma of natural killer lineage cells.
  Oshimi K. Oshimi K. Int J Hematol. 2003 Jul;78(1):18-23. doi: 10.1007/BF02983235. Int J Hematol. 2003. PMID: 12894846 Review.
• The development of T and non-T cell lineages from CD34+ human thymic precursors can be traced by the differential expression of CD44.
  Márquez C, Trigueros C, Fernández E, Toribio ML. Márquez C, et al. J Exp Med. 1995 Feb 1;181(2):475-83. doi: 10.1084/jem.181.2.475. J Exp Med. 1995. PMID: 7530757 Free PMC article.
• Hidden talents of natural killers: NK cells in innate and adaptive immunity.
  Cooper MA, Colonna M, Yokoyama WM. Cooper MA, et al. EMBO Rep. 2009 Oct;10(10):1103-10. doi: 10.1038/embor.2009.203. Epub 2009 Sep 4. EMBO Rep. 2009. PMID: 19730434 Free PMC article. Review.

References

1. 1. J Clin Invest. 1981 Oct;68(4):932-41 - PubMed
2. 1. Blood. 1993 Dec 15;82(12):3675-85 - PubMed
3. 1. J Immunol Methods. 1984 Aug 3;72(1):219-27 - PubMed
4. 1. Blood. 1986 Nov;68(5):1030-5 - PubMed
5. 1. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7575-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems
  • eScholarship, California Digital Library, University of California

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program